Skip Navigation

Private health care sector

Introducing rapid diagnostic tests in drug shops to improve the targeting of malaria from ACT Consortium on Vimeo.

 

Meetings and other information

 

Malaria rapid diagnostic tests (RDTs) and fever case management in the private health care sector in Africa: a consultative working meeting

 

Dates: Tue 20 and Wed 21 Oct 2015

Venue: Imperial Botanical Beach Hotel, Entebbe, Uganda

The meeting brought together nearly 60 invited participants, representing national malaria control authorities, device and drug regulatory agencies, international public health authorities (WHO/GMP), commercial and private diagnostic- and health-related interests in malaria-endemic countries, programme implementers, researchers, and funders. Participants systematically reviewed experience to date with malaria RDT implementation in private health care contexts in Africa, in order to generate preliminary guidance for countries implementing RDTs and fever case management in their private health care sectors.

 

AGENDA:

Day 1 – Tuesday, 20 October, 2015

Time

Topic

Presenter/s

Facilitator / Moderator

 9:00

Session 1: Setting the scene: Welcome, statement of meeting goals & objectives, and introductions

Anthony Mbonye

 

9:10

Global context, WHO perspective and anticipated “road map”

Jane Cunningham

Anthony Mbonye

9:20

Highlights from 2013 meetings, and review of published information on RDT introduction in the private sector

Theodoor Visser

 

9:30

Malaria testing and treatment market data from ACTwatch outlet surveys

Cristina Lussiana

 

9:40

Experience in Ghana: Lessons from AMFm, and how these inform introduction of RDTs to chemical sellers

Vivian Aubyn

 

9:50

Reactions, questions, comments

All

 

10:00

Session 2: Overview of meeting themes & format

Heidi Hopkins

 

10:10

Discussion – What role does the private sector play in broader health care systems?

All

Nikki Charman

10:30

Theme 1: National policies relevant to use of RDTs (Who is allowed to test, and where? Is private sector RDT use covered in existing policies? What adjustments may be needed?)

Presentation 1 / Presentation 2

Dickson Majige;    

Thomas Ilupeju

Peter Okui

11:15

Coffee/tea break

 

 

11:30 

Session 3: Theme 2: IVD (in vitro diagnostics) regulatory & licensing issues 

Presentation 1 / Presentation 2 / Presentation 3

Anderson Chinorumba

Patience Dabula

Denis William Mwesigwa

Simon Peter

Rugera

 

Theme 3: Engagement of private/commercial actors with government agencies (How can private and public health system components work together? What mechanisms promote effective interactions?)

Presentation 1 / Presentation 2

Vivian Aubyn        

Olua Uwandu

MC (Streat/Nakanwagi)

13:00

LUNCH

 

 

14:00 

Session 4: Theme 4: Quality control & assurance of diagnostics

Presentation 1 /  Presentation 2

Daniel Kyabayinze

Fidelis Mgohamwende

Denis Mwesigwa

 

Theme 5: Procurement, pricing & distribution logistics

Presentation 1 / Presentation 2

Nancy Njoki          

Grace Nakanwagi

Stephanie Dolan

15:30

Coffee/tea break

 

 

 15:45

Session 5: Theme 6: Market creation & stimulation

Presentation 1 / Presentation 2

Patricia Njiri

Elizabeth Streat

Nikki Charman

16:30

Theme 7: Monitoring & evaluation, and use of data (links with HMIS, national malaria surveillance)

Presentation 1 / Presentation 2 / Presentation 3

Olufemi Ajumobi

Brenda Mshiu

Catherine Goodman

Angus Spiers

17:15

Summary of Day 1, and plans for Day 2

 

John Cutler

17:30

Close of Day 1

 

 

 

Day 2 – Wednesday, 21 October, 2015

Time

Topic

Presenter/s

Facilitator / Moderator

 9:00

Session 6: Welcome and review of Day 2 program

  

Bosco Agaba

9:10

Theme 8: Treatment & case management challenges (approach to negative test results, adherence to test result & treatment, use of injections, use of antibiotics, integration with national iCCM/IMCI guidelines, waste management, other)

Presentation 1 / Presentation 2

Sigsbert Mkude

Phyllis Awor

Elizabeth Streat

Siân Clarke

10:00

Theme 9: Training & supervision mechanisms

Presentation 1 / Presentation 2

Cristina Lussiana

Robert Mugerwa

Theodoor Visser

10:45

Coffee/tea break

 

 

 11:00

Session 7: Theme 10: Vendor-provider incentives, financing & pricing (including overcharging, credit, insurance)

Richard Silumbe

Catherine Goodman

11:45

Theme 11: Communication to vendors, care providers and community members (information, education, and behavior change)

Presentation 1 / Presentation 2

Harriet Affran-Bonful

Robert Mugerwa

Siân Clarke

12:30

Theme 12: Linkages and referrals to public health systems (avoiding parallel or redundant systems)

Anthony Mbonye

Godwin Ntadom

Angus Spiers

13:15

LUNCH

 

 

 14:15

Session 8: Discussion and consensus (where possible) on recommendations in key areas – What can be recommended to countries in the near term? Where is research or additional information needed?

 All

 

15:45

Coffee/tea break

 

 

16:00

Continued group discussion of recommendations

All

 

17:00

Conclusions and next steps

All

Jane Cunningham; John Cutler

17:30

Close of Day 2

 

 

 

LIST OF PARTICIPANTS:

First row, left to right:

  Name Affiliation Professional Role
1 Mushabe Annet Brenda The Allied Health Professionals Council, Uganda Quality Assurance Officer / mRDT Focal Person
2 Vivian NA Aubyn Ghana National Malaria Control Program Partnerships, Planning & Resource Mobilization Focal Point (former AMFm Focal Point)
3 Cristine Betters Malaria Consortium (Uganda) Africa Programmes Director
4 Florence Camus-Bablon A2Meds (Access to Medicines) Consultant for RDT implementation
5 Elizabeth Shekalaghe Pharmacy Council, Tanzania Registrar
6 Anthony Mbonye Uganda Ministry of Health Director Health Services (Clinical & Community; and investigator, ACT Consortium of LSHTM)
7 Simon Peter Rugera Mbarara University of Science and Technology, Uganda Senior Lecturer; and Regional Consultant on Regulation of Medical Devices and in vitro diagnostics in the East Africa Community Partner States
8 Brenda Mshiu Population Services International (Tanzania) Program Manager – Malaria & Child Survival
9 Mary Muthigani  Medilink Lab & Surgicals Ltd (importer of SD Bioline in Uganda) Director
10 Phyllis Awor Makerere University School of Public Health Research Fellow
11 Serufusa Ronald Wakiso District Drugshop Owners Association, Uganda Patron, and District Drug Inspector
12 Sigsbert Mkude National Malaria Control Program, Tanzania Team Leader, Malaria Diagnosis & Treatment

Second row, left to right:

1 Godwin Ntadom National Malaria Programme, Nigeria Head, Case Management Branch
2 Harriet Affran-Bonful (delegate of Dr Evelyn Ansah) National Malaria Control Program, Ghana Pharmacist, member of evaluation team
3 Cristina Lussiana (delegate of Paul Hamilton) MalariaCare/Population Services International Malaria and Child Survival Monitoring Advisor (previously QA Advisor, UNITAID)
4 Wendy Prudhomme O'Meara Duke University; Moi University School of Public Health (Eldoret, Kenya) Associate Professor; Visiting Lecturer
5 Enywaku Alfred Uganda National Drug Authorigy (NDA) Liaison, UNITAID project
6 Young  Hong Access Bio (RDT manufacturer)  Lead, Biz Development
7 Alex Ogwal Clinton Health Access Initiative Malaria Program Manager, Uganda
8 Robert Mugerwa Malaria Consortium (Uganda) UNITAID Private Sector RDTs Uganda Project Manager
9 Daniel Kyabayinze FIND Uganda Study coordinator (and coordinator for diagnostics QA/QC, UNITAID)
10 Nancy Njoki Population Services International (Kenya) Child Survival Manager
11 Chidi Dozie Dozie & Dozie‘s Pharm Nigeria Ltd Pharmacist, first-line buyer of RDTs
12 Dickson Majige Private Health Facility Board, Tanzania Registrar
13 Elizabeth Streat Malaria Consortium (Uganda) Senior Public Health Specialist –Diagnostics; Technical Lead, UNITAID Private Sector RDTs project
14 Allison Enjetti ACT Consortium, London School of Hygiene & Tropical Medicine Logistics coordinator and rapporteur
15 Fidelis Mgohamwende National Malaria Control Program, Tanzania Head of Diagnostics
16 Agaba Bosco National Malaria Control Programme, Uganda National Coordinator, Case Management (Diagnostics)
17 Patience Dabula National Health Laboratory Service, South Africa National Manager, Quality Assurance
18 Comrade Olua Uwandu Lagos State Medicines Dealers Association (LSMDA) Secretary
19 Jane Cunningham Global Malaria Program, WHO Technical Officer, Diagnosis, Treatment & Vaccines Unit
20 Stephanie Dolan PSI / UNITAID (Kenya) PSI Deputy Director, UNITAID RDTs in the Private Sector Project
21 Luti Ojo DfID Funded Support to National Malaria Programme (SuNMaP), Nigeria Acting Commercial Sector Manager
22 Grace Nakanwagi Malaria Consortium (Uganda) UNITAID Private Sector RDTs Coordinator

Back row, left to right:

1 Ruth Aisabokhae Clinton Health Access Initiative Country team representative, Nigeria
2 Sammy Ogunjimi Codix Pharma Limited (RDT importer and distributor in Nigeria) Managing Director
3 Ifeanyi Obidike Bakan Gizo Nigeria Ltd Pharmacist, first-line buyer of RDTs
4 Olufemi Ajumobi National Malaria Programme, Nigeria Head, Surveillance & Data Management Unit
5 Jacob Lusekelo (delegate of Dr Fausta Mosha) National Health Laboratory, Ministry of Health and Social Welfare, Tanzania Diagnostic services
6 Francois Mwema Programme National de Lutte contre le Paludisme (national malaria control program), DR Congo Chef de Division Prise en Charge des Cas (Head, Case Management Division)
7 Anderson Chinorumba WHO Intercountry support (Harare, Zimbabwe) Malaria diagnostics quality assurance and training
8 Gareth Jones Clinton Health Access Initiative Country team representative, Uganda
9 Theodoor Visser Clinton Health Access Initiative Program Manager, Malaria Diagnosis
10 Robert Luyeye Population Services International / Association de Santé Familiale Country team representative, DR Congo
11 Heidi Hopkins ACT Consortium, London School of Hygiene & Tropical Medicine Senior Lecturer, physician, meeting coordinator
12 Richard Silumbe Clinton Health Access Initiative Country team representative, Tanzania
13 Angus Spiers USAID/President’s Malaria Initiative Senior Malaria Technical Advisor
14 Feroz Nawab Chemoquip Limited (RDT importer; Kenya) Owner
15 John Cutler WHO; UNITAID Malaria Portfolio Manager
16 Bright Ekweremadu Society for Family Health, Nigeria Managing Director
17 Catherine Goodman London School of Hygiene & Tropical Medicine Reader in Health Economics and Policy; and investigator, ACT Consortium of LSHTM
18 Ilupeju Thomas Pharmacists Council of Nigeria Deputy Director / Head of Public Relations & Programme Coordination Unit
19 Patricia Njiri Clinton Health Access Initiative Program Manager, Kenya
20 Nikki Charman  Population Services International (Kenya) Senior Technical Advisor, and Director, RDTs in the Private Sector Project
21 Siân Clarke ACT Consortium, London School of Hygiene & Tropical Medicine Senior Lecturer in Malaria Research & Control; and investigator, ACT Consortium of LSHTM

Present but not in photo:

1 Albert Peter Okui National Malaria Control Programme, Uganda Programme Manager
2 Charles Katureebe WHO (Uganda) WHO Country Advisor – Malaria
3 J David Katabaire Uganda Health Management Group (distributor of SD Bioline RDTs) Distribution of RDT kits, support to retailers
4 Denis Mwesigwa Uganda National Drug Authority (NDA) Senior Inspector
5 Maurine Murtagh International Diagnostics Centre, LSHTM CEO

 

Diagnostic Testing in the Retail Private Sector: Lessons Learned


Report meeting of the Roll Back Malaria Partnership - Case Management Working Group

Meeting held in London, 29-30 April 2013

Download the meeting minutes